Sulfamethoxazole USP from Japan
Sulfamethoxazole is a synthetic bacteriostatic sulfonamide antibiotic used primarily in combination with trimethoprim for treating urinary tract infections and respiratory infections. It falls under HTS 2935.90.95.00 as a sulfonamide derivative other than those specifically named in prior subheadings, classified as a separate chemically defined organic compound per Chapter 29 note (a).
Duty Rate — Japan → United States
21%
Rate breakdown
9903.04.628.5%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.4912.5%Except for products described in headings 9903.05.85–9903.05.92, articles the product of Japan, with an ad valorem (or ad valorem equivalent) rate of duty under column 1 less than 12.5 percent, as provided for in U.S. note 52 to this subchapter
Import Tips
• Provide Certificate of Analysis (COA) confirming USP grade and purity >99% to avoid reclassification or detention
• FDA registration required; ensure Drug Master File (DMF) is active for API imports